Consensus Thermo Fisher Scientific Inc.
Equities
TMO
US8835561023
Advanced Medical Equipment & Technology
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
529.36 USD | +1.63% | -0.05% | -0.27% |
Evolution of the Average Target: Thermo Fisher Scientific Inc.
Evolution of the Target Price: Thermo Fisher Scientific Inc.
Changes in Analyst Recommendations: Thermo Fisher Scientific Inc.
Analyst Opinion | 4m Revision of opinion | Divergence of analysts' opinions | Divergence of Target Price | Ecart obj. / dr | ||
---|---|---|---|---|---|---|
+23.53% | ||||||
-1.05% | ||||||
+26.08% | ||||||
+7.69% | ||||||
+15.89% | ||||||
+34.24% | ||||||
+10.32% | ||||||
+5.74% | ||||||
+19.16% | ||||||
+4.96% | ||||||
Average | +14.66% | |||||
Weighted average by Cap. | +14.56% |
Analysts' Consensus
Analyst Consensus Detail
Consensus revision (last 18 months)
Analysts covering the company
Nephron Research | |
CMB International | |
ARC Independent Research | |
Stephens Inc. | |
Redburn Atlantic | |
Morgan Stanley | |
Baird | |
Stifel Nicolaus | |
Citigroup | |
Wells Fargo Securities | |
Raymond James | |
Bernstein | |
Leerink Partners | |
RBC Capital Markets | |
Goldman Sachs | |
Barclays | |
Evercore ISI | |
TD Cowen | |
China Merchants | |
Wolfe Research | |
Argus | |
JPMorgan Chase | |
Deutsche Bank Securities | |
UBS | |
Jefferies & Co. | |
HSBC | |
BofA Securities | |
KeyBanc Capital Markets | |
Atlantic Equities | |
Morningstar | |
Credit Suisse | |
Cowen | |
SVB Securities LLC | |
SVB Leerink | |
BTIG | |
Benchmark Capital | |
J.P. Morgan Chase |
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- TMO Stock
- Consensus Thermo Fisher Scientific Inc.